PRELUDE CAPITAL MANAGEMENT, LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 164 filers reported holding ACCELERON PHARMA INC in Q4 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$928,000
+472.8%
5,391
+217.9%
0.02%
+155.6%
Q2 2020$162,000
+1925.0%
1,696
+987.2%
0.01%
Q4 2019$8,000
+300.0%
156
+164.4%
0.00%
Q3 2019$2,000
-33.3%
59
-3.3%
0.00%
Q2 2019$3,000
-97.9%
61
-98.0%
0.00%
-100.0%
Q1 2019$145,000
-88.6%
3,109
-86.0%
0.01%
-89.2%
Q3 2018$1,274,000
+129.5%
22,263
+94.7%
0.07%
+111.4%
Q2 2018$555,000
+2821.1%
11,437
+2187.4%
0.04%
+1066.7%
Q1 2015$19,000
-44.1%
500
-50.0%
0.00%
-25.0%
Q2 2014$34,0001,0000.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q4 2018
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 2$3580.00%
View complete list of ACCELERON PHARMA INC shareholders